HUT70745A - Pharmaceutical composition for treatment of disorders of respiratory tract and hypertension containing (3s,4r)-3,4-dihydro-2,2-dimethyl-4-(2-oxo-piperidinyl)-6-pentafluorethyl-2h-1-benzopyranol - Google Patents
Pharmaceutical composition for treatment of disorders of respiratory tract and hypertension containing (3s,4r)-3,4-dihydro-2,2-dimethyl-4-(2-oxo-piperidinyl)-6-pentafluorethyl-2h-1-benzopyranolInfo
- Publication number
- HUT70745A HUT70745A HU9401681A HU9401681A HUT70745A HU T70745 A HUT70745 A HU T70745A HU 9401681 A HU9401681 A HU 9401681A HU 9401681 A HU9401681 A HU 9401681A HU T70745 A HUT70745 A HU T70745A
- Authority
- HU
- Hungary
- Prior art keywords
- benzopyranol
- pentafluorethyl
- piperidinyl
- dihydro
- oxo
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919125862A GB9125862D0 (en) | 1991-12-05 | 1991-12-05 | Pharmaceutical composition |
| GB929213042A GB9213042D0 (en) | 1992-06-19 | 1992-06-19 | Pharmaceutical composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HU9401681D0 HU9401681D0 (en) | 1994-09-28 |
| HUT70745A true HUT70745A (en) | 1995-10-30 |
Family
ID=26299960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9401681A HUT70745A (en) | 1991-12-05 | 1992-12-01 | Pharmaceutical composition for treatment of disorders of respiratory tract and hypertension containing (3s,4r)-3,4-dihydro-2,2-dimethyl-4-(2-oxo-piperidinyl)-6-pentafluorethyl-2h-1-benzopyranol |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0615437A1 (hu) |
| JP (1) | JPH07501538A (hu) |
| AP (1) | AP382A (hu) |
| AU (1) | AU2954292A (hu) |
| BR (1) | BR9206845A (hu) |
| CA (1) | CA2125156A1 (hu) |
| CZ (1) | CZ136394A3 (hu) |
| HU (1) | HUT70745A (hu) |
| IL (1) | IL103952A0 (hu) |
| MA (1) | MA22731A1 (hu) |
| MX (1) | MX9206975A (hu) |
| RU (1) | RU94030464A (hu) |
| SI (1) | SI9200365A (hu) |
| SK (1) | SK65794A3 (hu) |
| WO (1) | WO1993010757A1 (hu) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3274350D1 (en) * | 1981-09-25 | 1987-01-08 | Beecham Group Plc | Pharmaceutically active benzopyran compounds |
| EP0093535B1 (en) * | 1982-04-28 | 1986-12-30 | Beecham Group Plc | Novel chromenes and chromans |
| IL86798A (en) * | 1987-06-23 | 1992-12-01 | Sanofi Sa | 2,2-dimethylchroman-3-ol derivatives, their preparation and pharmaceutical compositions containing them |
| ATE120459T1 (de) * | 1988-12-13 | 1995-04-15 | Beecham Group Plc | Benzopyran und verwandte verbindungen. |
-
1992
- 1992-12-01 RU RU94030464/14A patent/RU94030464A/ru unknown
- 1992-12-01 EP EP92923956A patent/EP0615437A1/en not_active Withdrawn
- 1992-12-01 AU AU29542/92A patent/AU2954292A/en not_active Abandoned
- 1992-12-01 SK SK657-94A patent/SK65794A3/sk unknown
- 1992-12-01 CA CA002125156A patent/CA2125156A1/en not_active Abandoned
- 1992-12-01 HU HU9401681A patent/HUT70745A/hu unknown
- 1992-12-01 CZ CZ941363A patent/CZ136394A3/cs unknown
- 1992-12-01 WO PCT/GB1992/002234 patent/WO1993010757A1/en not_active Application Discontinuation
- 1992-12-01 JP JP5509963A patent/JPH07501538A/ja active Pending
- 1992-12-01 BR BR9206845A patent/BR9206845A/pt not_active Application Discontinuation
- 1992-12-03 MA MA23021A patent/MA22731A1/fr unknown
- 1992-12-03 IL IL103952A patent/IL103952A0/xx unknown
- 1992-12-03 MX MX9206975A patent/MX9206975A/es unknown
- 1992-12-04 AP APAP/P/1992/000454A patent/AP382A/en active
- 1992-12-04 SI SI19929200365A patent/SI9200365A/sl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK65794A3 (en) | 1995-02-08 |
| EP0615437A1 (en) | 1994-09-21 |
| AP9200454A0 (en) | 1993-01-31 |
| HU9401681D0 (en) | 1994-09-28 |
| JPH07501538A (ja) | 1995-02-16 |
| CZ136394A3 (en) | 1995-02-15 |
| AP382A (en) | 1995-05-03 |
| AU2954292A (en) | 1993-06-28 |
| IL103952A0 (en) | 1993-05-13 |
| BR9206845A (pt) | 1996-01-02 |
| MA22731A1 (fr) | 1993-07-01 |
| SI9200365A (en) | 1993-06-30 |
| MX9206975A (es) | 1993-06-01 |
| RU94030464A (ru) | 1996-04-27 |
| WO1993010757A1 (en) | 1993-06-10 |
| CA2125156A1 (en) | 1993-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1022835A1 (en) | Pharmaceutical composition for treatment of diabetes | |
| NZ304901A (en) | Taxoid derivatives, preparation thereof and pharmaceutical compositions containing same | |
| PL342162A1 (en) | Galenic form for oral administration of either immediate or prolonged drug release containing an absorption enhancing agent and application of such absorption enhancing agent | |
| HUP9901243A3 (en) | Quinazoline derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds | |
| AU4645596A (en) | Pharmaceutical compositions for prevention and treatment of central nervous system disorders | |
| HUP9701694A3 (en) | Indolinone derivatives for the treatment of disease, use thereof, pharmaceutical compositions containing these compounds | |
| EP1221908A4 (en) | ORAL PHARMACEUTICAL COMPOSITIONS CONTAINING TAXANES AND METHODS OF TREATMENT IN WHICH SAID COMPOSITIONS ARE USED | |
| HUP0100950A3 (en) | Cyclic amino compounds, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them | |
| HUP9901159A3 (en) | Substituted benzylaminopiperidine derivatives and use thereof, pharmaceutical compositions containing these compounds | |
| HUP0000914A3 (en) | Atropisomers of 3-aryl-4(3h)-quinazolinones and pharmaceutical compositions containing them | |
| HUP9900413A3 (en) | Use of coralyne derivatives, new coralyne derivatives and use thereof, pharmaceutical compositions containing these new coralyne derivatives | |
| HUP0102203A3 (en) | Use of optically pure(+)-norcisapride for producing pharmaceutical compositions suitable for treating apnea, bulimia and other disorders | |
| HUP0100737A3 (en) | Use of phytosterol for preventing and delaying the onset of alzheimer's disease and phytosterol containing pharmaceutical compositions | |
| PL316528A1 (en) | Pharmaceutic compositions and drugs for prevetion and treatment of endothelial disorders | |
| CZ129596A3 (en) | Oxazolidinone derivative, process of its preparation and pharmaceutical composition containing thereof | |
| IL118636A (en) | Oral pharmaceutical compositions of S(+)-etodolac | |
| IL115073A (en) | Use of 5-substituted pyridine-and hexahydroquinoline-3-carboxylic acid derivatives for the preparation of pharmaceutical compositions for the treatment of disorders of the central nervous system some such novel compounds their preparation and pharmaceutical compositions containing them | |
| HUP9901326A3 (en) | Benzopyran derivatives having leukotriene-antagonistic action, pharmaceutical compositions containing these compounds, process for the preparation and use of these compounds and compositions | |
| AU5383196A (en) | Pharmaceutical compositions for prevention and treatment of central nervous system disorders | |
| HUP9802553A3 (en) | Use of carbonic anhydrase inhibitors for the preparation of pharmaceutical compositions increasing retinal blood flow | |
| HUT70745A (en) | Pharmaceutical composition for treatment of disorders of respiratory tract and hypertension containing (3s,4r)-3,4-dihydro-2,2-dimethyl-4-(2-oxo-piperidinyl)-6-pentafluorethyl-2h-1-benzopyranol | |
| HK1024695A1 (en) | Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them | |
| AU3690495A (en) | Pharmaceutical composition containing derivatives of sex hormones | |
| HUP0105426A3 (en) | Derivatives of 3-(2-oxo-[1,3']bipyrrolidinyl-3-ylidenemethyl)-cephems and pharmaceutical compositions thereof | |
| SG81198A1 (en) | Purified form of streptogramins, its preparation and pharmaceutical compositions containing it |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DFD9 | Temporary protection cancelled due to non-payment of fee |